US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

249.65

-16.1400-6.07%

Post-market: 251.001.35+0.54%16:26 EDT

Volume:439.09K

Turnover:113.70M

Market Cap:567.83M

PE:- -

High:271.79

Open:261.76

Low:248.93

Close:265.79

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.35

T/O Rate:19.30%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Health Care Select Sector SPDR: Pivot points

Wall Street Analysts Are Bullish on Top Healthcare Picks

Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test

ANI Pharmaceuticals Wins FDA Approval for Generic Everolimus Tablets

MT Newswires Live

Humanwell Healthcare Seeks Up to 3.5 Billion Yuan in Private Placement

MT Newswires Live

Celltrion Wins US FDA Nod for RA Trial of Zymfentra

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Codexis (CDXS) and VistaGen Therapeutics (VTGN)

Health Care Roundup: Market Talk

King-Friend Unit Gets US FDA Approval for Additional Amikacin Manufacturing Site

MT Newswires Live

Liaoning Cheng Da Subsidiary to Invest $5 Million in Healthcare Fund

MT Newswires Live

Golden Globe Resources lodges ASX corporate governance statement for FY2026

Golden Globe Resources Files 2026 Annual Report

Glenmark’s Goa Plant Secures U.S. FDA EIR With VAI Status

IHH Healthcare's Share-Price Retreat Likely Creates Entry Opportunity

HealthCo Healthcare & Wellness REIT (HCW) Receives a Sell from Morgan Stanley

China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review

MT Newswires Live

UBS Remains a Hold on Sonic Healthcare Limited (SHL)

AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":249.65,"timestamp":1790884800000,"preClose":265.79,"halted":0,"volume":439085,"hourTrading":{"tag":"盘后","latestPrice":251,"preClose":249.65,"latestTime":"16:26 EDT","volume":786,"amount":197370.2592,"timestamp":1790886361651,"change":1.35,"changeRate":0.005408,"amplitude":0.00701},"delay":0,"changeRate":-0.060724632228451085,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Post-Mkt","change":-16.14,"latestTime":"10-01 16:27:37 EDT","open":261.76,"high":271.79,"low":248.93,"amount":113698031.0635,"amplitude":0.086008,"askPrice":251.2,"askSize":40,"bidPrice":250.28,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.00362,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.6,"preClose":265.79,"latestTime":"09:29 EDT","volume":2318,"amount":612617.1732800001,"timestamp":1790861345993,"change":-4.19,"changeRate":-0.015764,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":251,"preClose":249.65,"latestTime":"16:26 EDT","volume":786,"amount":197370.2592,"timestamp":1790886361651,"change":1.35,"changeRate":0.005408,"amplitude":0.00701},"volumeRatio":1.351566,"impliedVol":0.9424,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.351566,"shares":2274486,"dividePrice":0.9037,"high":271.79,"amplitude":0.086008,"preClose":265.79,"low":248.93,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":249.65,"committee":-0.142857,"eps":0,"divideRate":0.00362,"volume":439085,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0823416689.USD","IBB","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU0109394709.USD","NKTR","LU0432979614.USD","LU1674673428.USD","LU0256863811.USD","LU1559883803.SGD","LU2362541513.USD","LU2237438978.USD","TBXU","LU2417539215.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","BK4023","LU0417517546.SGD","IE0002141913.USD","PBE","BK4007","LU1069344957.HKD","IE0002270589.USD","BK4585","LU0061475181.USD","BK4139","IE00B19Z3581.USD","LU0757428866.USD","HCSG","BIB","VRTX","LU2324357040.USD","SG9999001176.USD","XLV","IE00BFTCPJ56.SGD","LU0234570918.USD","IDNA","VERX","BBH","KYMR","LU1035775433.USD","XBI","GNMX","LU0289739699.SGD","SG9999001176.SGD","LU2089984988.USD","IBBQ","LABU","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669857344","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2669857344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669857344?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:26","pubTimestamp":1790166372,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $171.74, Pivot Low: $168.88. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-148?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-148?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669855424","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669855424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669855424?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:10","pubTimestamp":1790165442,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entera Bio (ENTX) and AbSci (ABSI) with bullish sent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","ABSI","BK4539","BK4585","XBI","BK4137","ENTX","BK4581","ARKG","XLV","HCSG","BK4121","LABU","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669835544","title":"Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669835544","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669835544?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:52","pubTimestamp":1790164320,"startTime":"0","endTime":"0","summary":"Trading in shares of Grail is halted on Wednesday ahead of a Food and Drug Administration advisory committee meeting to discuss the diagnostic company's proposed multi-cancer blood test.Grail is seeking FDA approval of Galleri, a blood test that aims to catch cancers before symptoms appear.Shares of the Menlo Park, Calif., company were up 34% this week through Tuesday's close after FDA briefing documents for the meeting, released on Monday, were more favorable than investors had expected.RBC Capital Markets analyst Dan Leonard said the briefing documents suggest the FDA is less concerned with Galleri's safety and effectiveness and more focused on how to label the commercial product.The FDA often turns to advisory committees to obtain advice from experts who work outside of the government when a scientific, technical or policy question arises, such as whether an unapproved product is safe and effective. The agency usually follows the advice of its advisory committees but it isn't bound ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4588","BK4139","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488800","title":"ANI Pharmaceuticals Wins FDA Approval for Generic Everolimus Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488800","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488800?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:18","pubTimestamp":1790162338,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals  received final approval from the US Food and Drug Administration for its abbreviated new drug application for Everolimus Tablets for Oral Suspension in 2mg, 3mg and 5mg strengths, the company said WednesdayThe product is the generic version of Afinitor Disperz, with US annual sales of the reference product totaling about $123 million based on July 2026 moving annual total IQVIA data, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANIP","LABU","BK4007","BK4588","LU1559883803.SGD","BK4585","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669010782","title":"Humanwell Healthcare Seeks Up to 3.5 Billion Yuan in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669010782","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669010782?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:14","pubTimestamp":1790158443,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare  is looking to raise up to 3.50 billion yuan from the sale of 234.1 million shares through a private placement, according to a Wednesday filing with the Shanghai Stock Exchange.The drug company will use the proceeds to fund research and development projects, manufacturing facilities, digitalization projects, and working capital.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK0185","BK0096","XLV","BK0070","XBI","BK0239","600079","BK4137","BK4581","BK4585","BK4588","HCSG","LABU","LU0128526141.USD","BK0012","LU0029874061.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669363104","title":"Celltrion Wins US FDA Nod for RA Trial of Zymfentra","url":"https://stock-news.laohu8.com/highlight/detail?id=2669363104","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669363104?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:29","pubTimestamp":1790155771,"startTime":"0","endTime":"0","summary":"Celltrion (KRX:068270) received U.S. Food and Drug Administration approval to launch a Phase 3 clinical trial in the U.S. for Zymfentra (CT-P13 SC), a subcutaneous version of its infliximab biosimilar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","ANAB","XLV","VRTX","BBH","LU2462157665.USD","LU1585245621.USD","VERX","DGX","LU1035775433.USD","BK4583","FFTY","IE00B2B36J28.USD","LU1093756325.SGD","LABU","SGXZ57979304.SGD","LU0823417737.USD","IE00BZ9MQY76.HKD","LU2506951875.HKD","LU0823416689.USD","LU0823417653.USD","LU1854103824.USD","LU0757428866.USD","LU2506952170.USD","LU0109394709.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU2456880835.USD","IBB","LU0079474960.USD","BK4567","XBI","TBXU","IE00BJT1NW94.SGD","IBBQ","IDNA","LU0417517546.SGD","LU1815336091.USD","LU2089984988.USD","LU0234570918.USD","LU2506952097.USD","SG9999001176.USD","HCSG","IE00BJJMRZ35.SGD","SG9999001176.SGD","PBE","BK4139","GNMX","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101316","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Codexis (CDXS) and VistaGen Therapeutics (VTGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669101316?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:50","pubTimestamp":1790153418,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Codexis (CDXS) and VistaGen Therapeutics (VTGN). Codexis (CDXS) I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-codexis-cdxs-and-vistagen-therapeutics-vtgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-codexis-cdxs-and-vistagen-therapeutics-vtgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","CDXS","VTGN","BK4585","BK4137","HCSG","BK4139","XLV","LU0029874061.USD","XBI","BK4121","LU0128526141.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669060401","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669060401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669060401?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:20","pubTimestamp":1790151600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0246 GMT - IHH Healthcare's 10% year-to-date share price decline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4588","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669082451","title":"King-Friend Unit Gets US FDA Approval for Additional Amikacin Manufacturing Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2669082451","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669082451?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:48","pubTimestamp":1790146114,"startTime":"0","endTime":"0","summary":"Nanjing King-Friend Biochemical Pharmaceutical  subsidiary Meitheal Pharmaceuticals received U.S. Food and Drug Administration approval to add a manufacturing site for amikacin sulfate injection.The product, which treats serious Gram-negative bacterial infections, will be manufactured at the company's facility, according to a Wednesday filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0186","BK4588","BK0046","603707","BK0239","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669910845","title":"Liaoning Cheng Da Subsidiary to Invest $5 Million in Healthcare Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2669910845","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669910845?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:42","pubTimestamp":1790145743,"startTime":"0","endTime":"0","summary":"Liaoning Cheng Da  subsidiary Chengda Steel Hong Kong will invest $5 million as a limited partner in a biopharmaceutical and healthcare fund, according to a Wednesday filing with the Shanghai bourse.The investment is equivalent to 12.95% of the Likon Venture Fund II Limited Partnership, which has so far raised $38.6 million.The fund will invest in innovative drugs, medical devices, medical diagnostic equipment and reagents, and related service areas.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","BK4581","BK0250","BK4585","XBI","BK0074","LU0029874061.USD","LU0128526141.USD","600739","BK4137","BK4588","LABU","BK0144","BK0188","BK0196","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177738","title":"Golden Globe Resources lodges ASX corporate governance statement for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177738?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:18","pubTimestamp":1790140709,"startTime":"0","endTime":"0","summary":"Reckon Health Care Holdings Ltd ( ($AU:GGR) ) has issued an announcement. Golden Globe Resources Limited has lodged its corporate governance statem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-lodges-asx-corporate-governance-statement-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-lodges-asx-corporate-governance-statement-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHRI","FDRX","ESGY","MDCP","PEMX","JSTC","ESG","XBI","EXEQ","HAPY","VOTE","SSPX","BK4581","ESGV","SUSA","LABU","HAPI","XLV","ESGA","ESML","NUSC","CVLC","LOPP","BK4588","BK4585","DSI","CDEI","NUDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669617778","title":"Golden Globe Resources Files 2026 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2669617778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669617778?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:18","pubTimestamp":1790140701,"startTime":"0","endTime":"0","summary":"Reckon Health Care Holdings Ltd ( ($AU:GGR) ) has provided an update. Golden Globe Resources Limited has released its annual report for the year en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-files-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-files-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","XBI","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174949","title":"Glenmark’s Goa Plant Secures U.S. FDA EIR With VAI Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669174949?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:32","pubTimestamp":1790134372,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) has provided an announcement. Glenmark Pharmaceuticals, a research-led global drugmaker with a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmarks-goa-plant-secures-u-s-fda-eir-with-vai-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmarks-goa-plant-secures-u-s-fda-eir-with-vai-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VAI","LABU","BK4166","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171988","title":"IHH Healthcare's Share-Price Retreat Likely Creates Entry Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171988","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171988?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:46","pubTimestamp":1790131560,"startTime":"0","endTime":"0","summary":"0246 GMT - IHH Healthcare's 10% year-to-date share price decline could offer a potential entry point, with its operations expected to improve across key markets, Kenanga IB analyst Raymond Choo Ping Khoon says in a note. Singapore operations are recovering, with bed occupancy rising above 52% in August and September compared with 51% in 2Q, he says. Performance in Turkey and Europe is also expected to improve in 2H as recent hospital acquisitions ramp up. In India, Gleneagles Healthcare's margins are expected to move closer to Fortis Healthcare's, while Greater China could provide further upside if losses narrow faster than expected, he adds. Kenanga upgrades IHH's rating on outperform from market perform, raises target price to 9.10 ringgit from 8.50 ringgit. Shares are 0.5% higher at 8.04 ringgit.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","LU0029874061.USD","HCSG","BK4585","XBI","BK4137","LABU","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179295","title":"HealthCo Healthcare & Wellness REIT (HCW) Receives a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179295?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:15","pubTimestamp":1790129717,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Lauren Berry maintained a Sell rating on HealthCo Healthcare & Wellness REIT today and set a price target of A$0.75. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/healthco-healthcare-wellness-reit-hcw-receives-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/healthco-healthcare-wellness-reit-hcw-receives-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVRA","MDIV","BK4588","XBI","XLV","YLDW","LABU","RJMG","BPRE","REIT","DFRA","RNTY","BK4581","BK4585","PSCF","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669176975","title":"China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2669176975","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669176975?lang=en_us&edition=fundamental","pubTime":"2026-09-23 09:27","pubTimestamp":1790126879,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation  said its subsidiary Chengdu Gaotong Isotope has successfully completed the U.S. Food and Drug Administration filing process for its lutetium-177, or Lu-177, active pharmaceutical ingredient DMF, according to a Tuesday Hong Kong bourse filing.The company said the filing clearance will streamline the drug registration process for downstream manufacturers by eliminating the need to submit supporting documentation for the API separately, potentially reducing review time and application costs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK1222","BK4588","BK6100","BK6520","01763","OTX.SI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669173181","title":"UBS Remains a Hold on Sonic Healthcare Limited (SHL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669173181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669173181?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:08","pubTimestamp":1790122129,"startTime":"0","endTime":"0","summary":"In a report released today, David Low from UBS maintained a Hold rating on Sonic Healthcare Limited, with a price target of A$21.20. Low covers the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120098","title":"AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120098?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:54","pubTimestamp":1790117646,"startTime":"0","endTime":"0","summary":"The latest announcement is out from AdAlta Ltd. ( ($AU:1AD) ). AdAlta has secured acceptance from the U.S. Food and Drug Administration for a pre‑I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adalta-wins-fda-preind-meeting-for-lead-cart-cancer-therapy-ew001?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adalta-wins-fda-preind-meeting-for-lead-cart-cancer-therapy-ew001?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":14,"totalSize":391,"code":"91000000","status":"200"}]}}